These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

284 related items for PubMed ID: 9882238

  • 1. [Alzheimer's disease. Foreword].
    Derquesné C.
    Rev Prat; 1998 Nov 01; 48(17):1871-2. PubMed ID: 9882238
    [No Abstract] [Full Text] [Related]

  • 2. No donepezil discontinuation effect in patients with Alzheimer's disease who were switched to rivastigmine after failing to benefit from donepezil treatment.
    Auriacombe S, Pere JJ, Rivage Study Group.
    Curr Med Res Opin; 2003 Nov 01; 19(8):715-7. PubMed ID: 14687442
    [No Abstract] [Full Text] [Related]

  • 3. [Alzheimer dementia. Comparison of the effectiveness of cholinesterase inhibitors and gingko].
    Gasser US, Gasser T.
    MMW Fortschr Med; 2001 Dec 13; 143(51-52):40-1. PubMed ID: 11824165
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Pharmacokinetics and drug interactions of cholinesterase inhibitors administered in Alzheimer's disease.
    Crismon ML.
    Pharmacotherapy; 1998 Dec 13; 18(2 Pt 2):47-54; discussion 79-82. PubMed ID: 9543465
    [Abstract] [Full Text] [Related]

  • 8. Dementia.
    Warner J, Butler R, Prabhakaran P.
    Clin Evid; 2003 Jun 13; (9):1010-33. PubMed ID: 12967405
    [No Abstract] [Full Text] [Related]

  • 9. Switching cholinesterase inhibitor therapy in Alzheimer's disease--donepezil to rivastigmine, is it worth it?
    Bullock R, Connolly C.
    Int J Geriatr Psychiatry; 2002 Mar 13; 17(3):288-9. PubMed ID: 11921158
    [No Abstract] [Full Text] [Related]

  • 10. The application of evidence-based principles of care in older persons (issue 5): Alzheimer's disease.
    Zarowitz BJ, Stefanacci R, Hollenack K, O'Shea T, Gruber J, Tangalos EG.
    J Am Med Dir Assoc; 2007 Mar 13; 8(3):183-93. PubMed ID: 17349948
    [No Abstract] [Full Text] [Related]

  • 11. Review of donepezil, rivastigmine, galantamine and memantine for the treatment of dementia in Alzheimer's disease in adults with Down syndrome: implications for the intellectual disability population.
    Prasher VP.
    Int J Geriatr Psychiatry; 2004 Jun 13; 19(6):509-15. PubMed ID: 15211527
    [Abstract] [Full Text] [Related]

  • 12. [Drug therapy strategies in Alzheimer's disease].
    Lacomblez L.
    Rev Prat; 1998 Nov 01; 48(17):1913-7. PubMed ID: 9854394
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Limited efficacy of cholinesterase inhibitors in Alzheimer's dementia].
    Kornhuber J.
    Fortschr Neurol Psychiatr; 2004 Oct 01; 72(10):553-4. PubMed ID: 15472777
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.